Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as a preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
Role Summary:
The Senior Director, Pricing and Reimbursement is an experienced and strategic leader who is responsible for developing and executing global pricing and market access strategies to ensure optimal market positioning, pricing, and patient access solutions for our innovative products.
This strategic leader establishes the overarching pricing and reimbursement strategy in alignment with the market access and commercialization strategy and has a proven track record of leading and coordinating strategic activities aimed at building, shaping, and accelerating access, securing reimbursement across global markets. They create effective and productive partnership with cross-functional partners to influence strategic clinical development and commercialization decisions, as well as driving and executing pricing and market access strategies to support the differential value of Dyne assets for payer and HTA stakeholders across all stages of the product lifecycle.
The person in this role has strong leadership skills, a broad understanding and deep experience of global pharmaceutical markets (US & global markets) and a proven track record of bringing products to market successfully.
This role is based in Waltham, MA.
Primary Responsibilities Include:
- Lead the development and implementation of global pricing and market access strategies for our late-stage and early pipeline products, including value proposition and messaging, payer engagement, early access programs, pricing strategies, market access plans, launch sequence optimization, pricing narratives, pricing policy and governance.
- Collaborate cross-functionally with HEOR, R&D, Program Teams, Commercial, Medical Affairs, and other teams to integrate pricing, reimbursement and market access considerations throughout product lifecycles
- Develop and communicate compelling value story narratives and messaging for payers, health technology assessment (HTA) bodies, and other stakeholders
- Develop market access and pricing strategies to optimize product value and patient access globally, including innovative non-traditional market access solutions and contracting approaches to meet evolving payer needs
- Ensure integration of market access and pricing strategies into clinical development plans, brand plans, launch strategies, and launch sequencing decisions
- Provide pricing guidance and assumptions for strategic planning, annual forecasting, and brand budget processes
- Develop resources and materials to be leveraged by the local teams in the engagement with market access stakeholders
- Collect actionable insights through market research, expert input forums, advisory boards, early payer advice, and engagement with external stakeholders
- Represent the company externally on pricing and market access topics with payers, policymakers, and industry groups
- Build, lead and coach a high-performing global pricing and reimbursement team
- Represent Dyne pricing and market access on key senior-level governance forums, working groups, and teams
- Understand and abide by global compliance regulations
Education and Skills Requirements:
- Advanced degree (PhD, PharmD, MD, or MBA) in a relevant field)
- 12+ years of experience in pharmaceutical/biotech industry with significant leadership experience in global pricing, reimbursement and market access roles
- 5+ years’ experience in people management, with experience building and leading high-performing global teams
- Deep understanding of global healthcare systems, pricing dynamics, and market access requirements
- Proven track record developing successful global pricing and market access strategies for specialty and rare disease products
- Excellent communication and presentation skills, with ability to influence senior leadership
- Experience building and leading high-performing global teams
- Strategic mindset with ability to navigate complex stakeholder environments
- Ability to travel globally on a regular basis
#LI-Onsite
The pay range reflects the base pay range Dyne reasonably expects to pay for this role at the time of posting. Individual compensation depends on factors such as education, experience, job-related knowledge, and demonstrated skills.
The statements contained herein reflect general details as necessary to describe the principles functions for this job, the level of knowledge and skill typically required, and the scope of responsibility, but should not be considered an all-inclusive listing of work requirements. Individuals may perform other duties as assigned, including work in other functional areas to cover absences or relief, to equalize peak work periods or otherwise balance workload.
Dyne Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.
Skills Required
- Advanced degree (PhD, PharmD, MD, or MBA) in a relevant field
- 12+ years of experience in pharmaceutical/biotech industry with significant leadership experience in global pricing, reimbursement and market access roles
- 5+ years' experience in people management, with experience building and leading high-performing global teams
- Deep understanding of global healthcare systems, pricing dynamics, and market access requirements
- Proven track record developing successful global pricing and market access strategies for specialty and rare disease products
- Excellent communication and presentation skills, with ability to influence senior leadership
- Strategic mindset with ability to navigate complex stakeholder environments
What We Do
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue seen with other approaches. Dyne has a broad portfolio of programs for serious muscle diseases, including candidates for myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com.
.png)
